Glycoprotein detection method and probe based on boric acid recognition effect

Through the glycoprotein detection method based on boric acid recognition, the positive feedback mechanism of the DNA circuit is used to construct the CHA and CHR reaction, which solves the problem of insufficient amplification of glycoprotein detection signal in the prior art, and achieves high sensitivity and versatility, which is particularly applicable Detection of glycoproteins related to bone health.

CN118914560AInactive Publication Date: 2024-11-08CHANGSHU NO 2 PEOPLES HOSPITAL
View PDF 0 Cites 3 Cited by

Patent Information

Application Number
CN202410965841.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-18
Publication Date
2024-11-08
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

In the existing glycoprotein detection methods, the signal amplification effect of enzymes or nanomaterials is inadequate, such as high cost, poor stability, and complex process, resulting in poor detection effect and different effects on the improvement of probes, making it difficult to meet high sensitivity and rapidity. Diagnostic requirements.

Method used

Using a glycoprotein detection method based on boric acid recognition, a DNA circuit containing a positive feedback mechanism with CHA and CHR as basic reaction units was constructed by initiating probe T and six plug-in ring probes H1, H2, H3, H4, H5, and H6. , realize signal amplification, especially suitable for the detection of bone health-related glycoprotein markers.

Benefits of technology

It significantly enhances the detection signal, improves detection sensitivity, realizes signal amplification, is convenient and versatile, and is suitable for a variety of glycoprotein detection, especially suitable for the detection of bone health-related glycoprotein markers such as OPN and OC, and the detection method is simple, High sensitivity.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118914560A_ABST
    Figure CN118914560A_ABST
Patent Text Reader

Abstract

The invention provides a glycoprotein detection method and probe based on boric acid recognition. The probe for glycoprotein detection based on boric acid recognition comprises an initiation probe T and six hairpin ring probes H1, H2, H3, H4, H5 and H6, the initiation probe T comprises a core fragment and a polyT fragment, and the core fragment comprises a sequence as shown in SEQ ID NO: 7. The probe can mediate a DNA circuit with a positive feedback mechanism, and the DNA circuit is composed of a CHA stage and a CHR stage. Specifically, on one hand, CHA and CHR are natural and have certain signal amplification capability; on the other hand, a positive feedback mechanism exists between the CHA reaction and the CHR reaction, the CHA reaction and the CHR reaction can be continuously carried out in a positive feedback mode, and the signal amplification effect is further enhanced.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present application relates to the field of biological detection technology, and specifically to a glycoprotein detection method and probe based on boric acid recognition. Background Art

[0002] Glycoproteins are the most common type of proteins. They have multiple roles and functions in organisms and are also of important clinical diagnostic value. Currently, most of the protein disease markers used for disease diagnosis are glycoproteins.

[0003] Highly sensitive electrochemical aptamer detection can directly analyze relevant biomarkers in complex samples, thereby achieving rapid diagnosis, treatment and monitoring. In order to achieve highly sensitive electrochemical aptamer detection of glycoproteins, existing methods generally rely on the signal amplification effect of enzymes or nanomaterials, but both have shortcomings such as high cost, poor stability and complex processes. At present, there have been studies on improving probes and constructing reaction systems to improve detection effects, but the effects vary. Therefore, related technologies in this field still need to be further developed. Summary of the invention

[0004] The present application provides a glycoprotein detection method and probe based on boric acid recognition, which can effectively trigger a DNA circuit containing a positive feedback mechanism with catalytic hairpin loop assembly (CHA) and cascade hybridization reaction (CHR) as basic reaction units, significantly enhancing the signal, especially targeting the detection of bone health-related glycoprotein markers such as osteopontin (OPN) and osteocalcin (OC).

[0005] One object of the present application is to provide a glycoprotein detection probe based on boric acid recognition, comprising a trigger probe T and six hairpin loop probes H1, H2, H3, H4, H5, and H6, wherein the trigger probe T comprises a core fragment and a polyT fragment, wherein the core fragment comprises a sequence as shown in SEQ ID NO: 7,

[0006] The probe H1 is partially complementary to the core fragment of the trigger probe T, and the probe H1 and the trigger probe T hybridize to form a T-H1 double strand.

[0007] The probe H2 is partially complementary to the probe H1, and the probe H2 hybridizes to form a H1-H2 double strand, exposing a single strand fragment I.

[0008] The probe H3 is partially complementary to the single-stranded fragment I, the probe H4 is partially complementary to the single-stranded fragment I, the probe H5 is partially complementary to the probe H4, the probe H5 is labeled with a fluorescent group and a quenching group, the probe H6 is partially complementary to the probe H5, and H3, H4, H5 and H6 hybridize in sequence in the presence of the single-stranded fragment I to form a long chain I-(H3-H4-H5-H6)n, and the long chain I-(H3-H4-H5-H6)n exposes the sequence of the triggering probe T.

[0009] Preferably, the fluorescent group includes FAM, JOE, Cy3 or TAMRA, and the quenching group includes BHQ1, BHQ2 or Dabcyl.

[0010] Preferably, the fluorescent group and the quencher group are modified at both ends of the probe, respectively.

[0011] Preferably, the polyT fragment is 6 to 8 consecutive thymines.

[0012] Preferably, the probe H1 includes a 5'-TCTCTATCATTAGTCGGCTTCATCTTCATCTCCGACTAATGATAAGAACA CTC-3' (SEQ ID NO: 1) sequence, the probe H2 includes a 5'-TCGGCTTCATCTTCATCTCCGACACTCTCTCTATCATTAGTCGGAGATG AAGATGAAGCCGACTAATG-3' (SEQ ID NO: 2) sequence, the probe H3 includes a 5'-GAGTGTCGGAGATGAAGATGAAGCCATCGTGCTTCATCTTCATCTCCG-3' (SEQ ID NO: 3) sequence, the probe H4 includes a 5'-GAGTGTTGCTTCATCTTCATCTCCGGTTTTGCGGAGATGAAGATGAAG CACGATG-3' (SEQ ID NO: 4) sequence, and the probe H5 is a sequence of 5'-CAAAACCGGAGATGAAGATGAAGCTTGCCTGCTTCATCTTCATCTCCG-3' (SEQ ID NO: 5), a FAM fluorescent group is labeled between the 12th and 13th positions, and a BHQ1 quenching group is labeled between the 42nd and 43rd positions, and the specific sequence is 5'-CAAAACCGGAGA / FAM / TGAAGATGAAGCTTGCCTGCTTCATCTTCA / BHQ1 / TCTCCG-3', and the probe H6 includes a 5'-GCTTCATCTTCATCTCCGACACTCCGGAGATGAAGATGAAGCAGGCAA CTCTATCATTAGTCG-3' (SEQ ID NO: 6) sequence.

[0013] The present application also includes the use of any of the above-mentioned probes in the detection of glycoproteins based on boronic acid recognition.

[0014] The present application also includes the use of any of the probes described in the preparation of glycoprotein detection products based on boric acid recognition.

[0015] Another object of the present application is to provide a glycoprotein detection method based on boric acid recognition, using any of the above-mentioned probes for detection, comprising the following steps:

[0016] (1) Taking the activated magnetic bead solution for magnetic separation, after washing, the carboxyl group on the surface of the magnetic beads is coupled with the amino group at the end of the target protein nucleic acid aptamer to obtain aptamer-functionalized magnetic beads (Apt@MBs).

[0017] (2) After the activation of the trigger probe T, the carboxyl group at the terminal of the trigger probe T is coupled with the amino group of the compound A having both an amino group and a phenylboronic acid group to obtain the modified trigger probe T (PBA-T).

[0018] (3) Apt@MBs and the sample to be tested are reacted, washed, the obtained magnetic beads are resuspended, PBA-T is added to the resuspended solution for reaction, washed, the obtained magnetic beads are resuspended, and the probes H1, H2, H3, H4, H5, and H6 are added to the resuspended solution for reaction in sequence.

[0019] (4) Measure the fluorescence signal of the supernatant obtained in step (3).

[0020] Preferably, the activation reagent used in step (1) is 1-ethyl-(3-dimethylaminopropyl)carbodiimide or NHS, and the activation reagent used in step (2) is NHS and N-(3-dimethylaminopropyl)-N'-ethylcarbodiimide hydrochloride.

[0021] Preferably, the compound A in step (2) is 3-aminophenylboronic acid (3-APBA).

[0022] Preferably, any of the above-mentioned glycoprotein detection methods based on boric acid recognition is used in the detection of OPN or OC.

[0023] Beneficial effects achieved by the technical solution of this application:

[0024] First, the probe of the present application can mediate a DNA circuit with a positive feedback mechanism, and the DNA circuit consists of two stages, CHA and CHR. Specifically, on the one hand, both CHA and CHR naturally have certain signal amplification capabilities. For example, with the help of CHA, a trigger probe T can mediate multiple cycles of assembly hybridization of H1 and H2 to form n H1-H2 double-stranded products, resulting in a 1:n signal amplification effect; with the help of CHR, a trigger single-stranded fragment I can mediate the sequential hybridization of multiple groups of H3, H4, H5 and H6 to form a long chain I-(H3-H4-H5-H6) n , and also produces a 1:n signal amplification effect. On the other hand, in the present application, there is a positive feedback mechanism between the two reactions of CHA and CHR, that is, the product of the CHA reaction can start the CHR reaction, and the product of the CHR reaction can also serve as the starting molecule of the CHA reaction. The two reactions can be carried out continuously in a positive feedback manner, further enhancing the effect of signal amplification.

[0025] Second, the detection method of the present application has high sensitivity, and can realize CHA and CHR continuously in a positive feedback manner, realizing complementary hybridization of triggering probes T, H1, H2, H3, H4, H5, H6 and other probes, so that the fluorescent group and the quenching group marked at both ends of probe H5 are spatially far away from each other, generating a significantly amplified fluorescent signal, and realizing signal amplification.

[0026] Third, the detection method of the present application is convenient and universal. The activated DNA circuit of boric acid affinity recognition is applicable to any glycoprotein and can be used for other glycoproteins or sugar-containing substances by simply replacing the nucleic acid aptamer used.

[0027] Fourth, the probe and detection method of the present application have been extensively verified and are particularly suitable for the detection of bone health-related glycoprotein markers such as OPN and OC. BRIEF DESCRIPTION OF THE DRAWINGS

[0028] Figure 1 Schematic diagram of the principle of glycoprotein detection method based on boric acid affinity recognition and activation of DNA circuit.

[0029] Figure 2 Gel electrophoresis characterization results of DNA circuits.

[0030] Figure 3 Fluorescence spectrum characterization results of DNA circuits.

[0031] Figure 4 Figure 2 is a flow cytometric analysis of aptamer and boronic acid affinity recognition.

[0032] Figure 5 This is the test result diagram for feasibility verification.

[0033] Figure 6 The figure is the test result of specificity verification.

[0034] Figure 7 This is a graph showing the fluorescence emission intensity detection results at different OPN concentrations.

[0035] Figure 8 This is a linear relationship diagram between the fluorescence emission intensity and the logarithmic value of OPN concentration.

[0036] Fig. 9 The results of OPN detection in buffer and simulated serum samples are shown in Figure 2.

[0037] Fig.10 This is the analytical performance diagram of OC detection. DETAILED DESCRIPTION

[0038] The following will be combined with the accompanying drawings to clearly and completely describe the technical solutions in the embodiments of the present application. Obviously, the described embodiments are only part of the embodiments of the present application, not all of the embodiments. Based on the embodiments in the present application, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of this application.

[0039] Specific mechanism of CHA reaction: The initiating probe T acts as the initiating chain, which can first open the hairpin structure of H1 and produce a T-H1 double strand. At this time, the single-stranded fragment exposed by H1 can further trigger the opening of the H2 hairpin structure, forming an intermediate structure T-H1-H2. Then, the single-stranded fragment exposed by H2 causes T to shift, eventually producing a double-stranded hybrid structure H1-H2, and the released T strand can further activate a new round of hybridization of H1 and H2. At the same time, according to the design, the CHA product H1-H2 exposes a single-stranded I fragment, which can initiate the subsequent CHR reaction.

[0040] Specific mechanism of CHR reaction: When the single-stranded I fragment is present, the hairpin structure of H3 is first opened and reacts with the I strand to produce the I-H3 complex. The exposed H3 single-stranded fragment can further open the hairpin structure of H4 to form the complex I-H3-H4. The newly exposed H4 single-stranded fragment can then serve as the target strand to open the hairpin structures of H5 and H6 in turn to form the I-(H3-H4-H5-H6), which can further trigger the cascade hybridization of H3 to H6, and finally produce the I-(H3-H4-H5-H6)n complex. At the same time, according to the design, the CHR product I-(H3-H4-H5-H6)n can expose the analog of the CHA reaction initiating strand T (same as the core fragment sequence of the initiating probe T), which can reversely trigger the CHA reaction, so that the two reactions can be carried out continuously in a positive feedback manner to achieve excellent signal amplification.

[0041] The principle of the glycoprotein detection method based on boric acid affinity recognition and activation of DNA circuit is as follows Figure 1As shown. When the target protein exists, Apt@MBs can capture and enrich the target glycoprotein through a specific molecular recognition process. Subsequently, PBA-T can be anchored to the protein surface by the interaction between phenylboronic acid and the sugar chain in the target glycoprotein molecule to form a sandwich complex. After magnetic separation, the probe T anchored on the surface of the magnetic bead can effectively trigger a DNA circuit containing a positive feedback mechanism with catalytic hairpin assembly (CHA) and cascade hybridization reaction (CHR) as basic reaction units, achieving complementary hybridization of six hairpin probes H1, H2, H3, H4, H5, and H6, so that the fluorescent group FAM and the quenching group BHQ marked at both ends of the probe H5 are far away from each other in space, generating a significantly amplified fluorescence signal for quantitative detection of the target glycoprotein.

[0042] The glycoprotein detection probe based on boric acid recognition includes a trigger probe T and six hairpin probes H1, H2, H3, H4, H5, and H6, all of which are designed based on the principle. The trigger probe T includes a core fragment and a polyT fragment, and the core fragment includes 5'-GAGTGTTCTCTATCATTAGTCGG-3' (SEQ ID NO: 7),

[0043] The probe H1 is partially complementary to the core fragment of the initiating probe T, and can form a T-H1 double strand by hybridization through a strand displacement reaction with the exposed single-stranded fragment of H1 as a fulcrum. There is a polyT fragment consisting of 6 to 8 consecutive thymines (T) between the core fragment of the initiating probe T and the terminal modified carboxyl group, so as to ensure that the core fragment of T has a certain spatial distance from the protein surface after PBA-T binds to the protein, and to ensure the smooth progress of the strand displacement reaction in which T participates.

[0044] The probe H2 is partially complementary to the probe H1, and the probe H2 undergoes a strand displacement reaction with the T-H1 double strand to form an H1-H2 double strand, exposing a single-stranded fragment I, thereby inducing a CHR reaction through hybridization with the H3 probe.

[0045] The probe H3 is partially complementary to the single-stranded fragment I, the probe H4 is partially complementary to the single-stranded fragment I, and the probe H5 is partially complementary to the probe H4. The probe H5 is labeled with a fluorescent group and a quenching group, and the fluorescent group may include FAM, JOE, Cy3 and TAMRA, preferably FAM, and the quenching group may include BHQ1, BHQ2 and Dabcyl, preferably BHQ1. The fluorescent group and the quenching group are far away from each other in space, for example, they can be modified at both ends of the probe respectively. The probe H6 is partially complementary to the probe H5. Under room temperature conditions, H3, H4, H5, and H6 self-assemble in the solution to form a hairpin ring structure, and can coexist stably. In the presence of the single-stranded fragment I, H3, H4, H5 and H6 hybridize in sequence to form a long chain I-(H3-H4-H5-H6)n. The long chain I-(H3-H4-H5-H6)n exposes the sequence of the trigger probe T and can continue to trigger the CHA reaction involving H1 and H2.

[0046] A glycoprotein detection method based on boric acid recognition comprises the following steps:

[0047] (1) Activating magnetic beads. The activation reagent is 1-ethyl-(3-dimethylaminopropyl) carbodiimide or NHS. The activated magnetic bead solution is subjected to magnetic separation. After washing, the carboxyl groups on the surface of the magnetic beads are coupled with the amino groups at the ends of the target protein nucleic acid aptamers to obtain Apt@MBs.

[0048] (2) Activating the initiator probe T, the activation reagents are NHS and N-(3-dimethylaminopropyl)-N'-ethylcarbodiimide hydrochloride. After the activation of the initiator probe T, the carboxyl group at the end of the initiator probe T is coupled with the amino group of 3-APBA to obtain PBA-T.

[0049] (3) Apt@MBs and the sample to be tested are reacted at 20-25°C for 0.5-1 hour. After the reaction is completed, magnetic separation is performed and the supernatant is discarded. The magnetic beads are washed, the solution is subjected to magnetic separation, and the supernatant is discarded. The washing process can be repeated. The obtained magnetic beads are resuspended, PBA-T is added to the resuspended solution, and the reaction is carried out at 20-25°C for 0.5-1 hour. The solution is subjected to magnetic separation and the supernatant is discarded. The magnetic beads are washed, the solution is subjected to magnetic separation and the supernatant is discarded. The washing process can be repeated. The obtained magnetic beads are resuspended, and the probes H1, H2, H3, H4, H5, and H6 are added to the resuspended solution in sequence at a concentration of 4-5 μM, and the reaction is carried out at 20-25°C for 1-2 hours. After the reaction is completed, the solution is placed in a magnetic field for magnetic separation and the supernatant is collected.

[0050] (4) Measure the fluorescence signal of the supernatant obtained in step (3).

[0051] The above-mentioned glycoprotein detection method based on boric acid recognition is preferably used in the detection of OPN or OC. However, by simply replacing the sequence of the target protein aptamer used, this method can be very conveniently used for the detection of other glycoproteins, such as carcinoembryonic antigen (CEA), alpha-fetoprotein (AFP), and mucin 1 (MUC1).

[0052] Example 1

[0053] The glycoprotein detection probe based on boric acid recognition includes a trigger probe T and six hairpin loop probes H1, H2, H3, H4, H5, and H6, and their sequences are listed in Table 1.

[0054] Table 1

[0055]

[0056]

[0057] Gel electrophoresis of DNA circuits Figure 2 shown.

[0058] Figure 1 A: Gel electrophoresis characterization of the CHA reaction system that constitutes the DNA circuit.

[0059] The PAGE images in the figure show the results of the CHA reaction when different DNA probes are present in the system. Lanes 1 to 3 show the bands after annealing of single-stranded H1, H2 and T, respectively. When H1 and H2 are annealed and reacted at 37°C, only two bands originating from H1 and H2 are observed in lane 4, indicating that the two will not assemble in the absence of the initiator chain T. When H1 and H2 are mixed and annealed at 95°C, a DNA complex with a larger molecular weight can be observed in lane 5, indicating that under the annealing treatment conditions, the original hairpin structure of H1 and H2 will be opened and base complementary pairing will be performed to form a double-stranded hybrid structure H1-H2, and the location of the H1-H2 band is also clearly shown. Furthermore, when annealed H1 and T are input into the system and reacted at 37°C, a band with a molecular weight between the single-stranded H1 and the double-stranded hybrid structure H1-H2 is observed in lane 6. This band originates from the T-H1 complex formed by the reaction of T and H1. When H1, H2 and T existed in the system at the same time, two bands, T-H1 in lane 6 and H1-H2 in lane 5, appeared in lane 7, verifying that in the presence of H1, H2 and T, the CHA reaction can proceed effectively according to the designed pathway.

[0060] Figure 1 B: Gel electrophoresis characterization of the complete DNA circuit.

[0061] The PAGE image in the figure shows the results of DNA circuit operation when different DNA probes are present in the solution. Lanes 1 to 4 show the annealed bands of single-stranded H3, H4, H5, and H6, respectively. When annealed H3, H4, H5, and H6 are added to the system at the same time and reacted at 37°C, it is observed that the position of the band in lane 5 is the same as the position of the bands in lanes 1, 2, 3, and 4 after the combination, indicating that the original hairpin structure of the four DNA hairpin probes will not open spontaneously and cannot undergo self-assembly reaction. After the initiator chain I is added and the system is placed at 37°C for reaction, it is observed that a DNA complex with a larger molecular weight is formed in lane 6, indicating that the presence of the initiator chain I triggers the assembly reaction of the four DNA hairpin probes. On the other hand, when annealed H1, H2, H3, H4, H5, and H6 are present in the system at the same time, after reacting at 37°C, the position of the band in lane 7 is the same as the position of these hairpin probes, indicating that these probes will not undergo spontaneous assembly reaction. In contrast, when the initiator chain T was further added to the system and the system was placed at 37°C for reaction, a DNA complex with a larger molecular weight was formed in lane 8, indicating that the presence of the initiator chain T can effectively activate the DNA circuit.

[0062] Fluorescence spectroscopy characterization of DNA circuits Figure 3 As shown, left: fluorescence spectrum of the complete DNA circuit, and right: fluorescence kinetic characterization. The red curve is a complete DNA circuit system containing activation probe T and 6 hairpin loop probes H1-H6; the yellow curve is a control system containing only 6 hairpin loop probes H1-H6.

[0063] Flow cytometric validation of aptamer and boronic acid affinity recognition, e.g. Figure 4 As shown. Case A: A complete system containing Apt@MBs, target protein OPN and FAM@PBA-T at the same time. PBA-T was additionally labeled with FAM as a source of fluorescence signal in flow cytometry analysis. Case B: A blank control system containing only Apt@MBs and FAM@PBA-T. Case C: A control system containing Apt@MBs, target protein OPN and FAM@T (control probe without phenylboronic acid modification); this system is used to verify that the anchoring of probe T to the magnetic bead surface is through the interaction between phenylboronic acid and sugar chains. Case D: A control system containing ssDNA@MBs (control magnetic beads using random DNA instead of specific aptamers, the ssDNA sequence is shown in Table 1), target protein OPN and FAM@PBA-T; this system is used to verify that the binding of the probe target protein to the magnetic bead surface is through the specific molecular recognition process between it and the nucleic acid aptamer.

[0064] The present invention relates to a glycoprotein detection method based on boric acid recognition and feasibility verification of the method:

[0065] (1) Preparation of Apt@MBs, the specific process is as follows: 300 μL of 2 mg / mL NHS-activated magnetic bead solution (purchased from Thermo Scientific Pierce) was taken for magnetic separation; the obtained magnetic beads were resuspended in 1 mL of 1 mM hydrochloric acid solution for washing, and then the solution was magnetically separated and the supernatant was discarded; the above washing process was repeated twice. The obtained magnetic beads were resuspended in 300 μL of Tris-HCl buffer containing 10 μM amino-modified OPN nucleic acid aptamer, and reacted at 25°C for 1 hour (during the reaction, the solution was shaken for 10 seconds every 15 minutes); thereafter, the solution was magnetically separated, the supernatant was discarded, and the obtained magnetic beads were resuspended in 300 μL of 1× phosphate buffer and stored at 4°C for later use.

[0066] It should be noted that the sequence of the OPN nucleic acid aptamer is 5′-TGTGTGCGGCACTCCAGTCTGTTACGCCGC-3′ (SEQ ID NO: 10), and the sequence of the amino-modified OPN nucleic acid aptamer is shown in Table 1.

[0067] (2) Preparation of PBA-T and control probe PBA-cT. The specific process is as follows: 200 μL of 2 μM priming probe T (SEQ ID NO: 8) or control probe cT (SEQ ID NO: 9) was mixed evenly with 200 μL of 10 μM NHS (CAS No. 6066-82-6, purchased from Sigma-Aldrich) and N-(3-dimethylaminopropyl)-N'-ethylcarbodiimide hydrochloride (CAS No. 25952-53-8, purchased from Sigma-Aldrich), and reacted at 37°C for 1 hour; then, 100 μL of 100 μM 3-APBA was added, and the reaction was carried out at 37°C for 2 hours; the reaction mixture was transferred to a centrifugal ultrafiltration tube using a 3,000 Dalton molecular weight cutoff ultrafiltration membrane, and centrifuged at 4°C and 14000g for 15 minutes to remove unreacted 3-APBA; the ultrafiltration product (i.e., PBA-T or PBA-cT) was redissolved in 200 μL of Tris-HCl buffer and stored in a 4°C refrigerator.

[0068] (3) Take 100 μL of Apt@MBs prepared in step (1) and 50 μL of the test solution (including the sample solution containing 100 ng / mL target glycoprotein OPN and the blank control solution without any protein) in a microtube and react at 25°C for 1 hour; after the reaction, the solution is magnetically separated and the supernatant is discarded. The obtained magnetic beads are washed with 1× phosphate buffer, and then the solution is magnetically separated and the supernatant is discarded. Repeat the above washing process twice. The obtained magnetic beads are resuspended in 150 μL of 1× phosphate buffer.

[0069] Take 50 μL of the PBA-T and control probe PBA-cT solutions prepared in step (2) that cannot activate the downstream DNA circuit and add them to the obtained magnetic bead resuspension solution, mix well and place at 25°C for reaction for 0.5 hours; after the reaction is completed, the solution is magnetically separated and the supernatant is discarded; the obtained magnetic beads are washed with 1× phosphate buffer, and then the solution is magnetically separated and the supernatant is discarded; repeat the above washing process twice. The obtained magnetic beads are resuspended in 200 μL of 1× phosphate buffer.

[0070] 10 μL of 4 μM probe H1, H2, H3, H4, H5, H6 solution and 140 μL of 1× phosphate buffer were added to the magnetic bead resuspension solution, mixed evenly and placed at 25°C for 1.5 hours. After the reaction, the solution was placed under a magnetic field for magnetic separation, and the supernatant was collected.

[0071] (4) Using a fluorescence spectrometer to measure the fluorescence signal of the supernatant obtained in step (3). The experimental conditions used are: excitation wavelength 480nm, emission wavelength scanning range 505~600nm. The detection results are as follows Figure 5 shown.

[0072] Figure 5 The fluorescence emission spectra obtained when the fluorescence detection method of the present application is used to detect 100 ng / mL OPN and the control group are shown. When 100 ng / mL OPN is present in the detection system, the solution has an obvious fluorescence emission peak near 520 nm; on the contrary, when the detection system is a blank control without OPN, the solution has only a very small background signal peak near 520 nm. When PBA-cT, which cannot activate the DNA circuit, is used for OPN detection, the fluorescence emission of the solution near 520 nm is equivalent to that of the blank control. These results show that the target glycoprotein OPN can cause a significant increase in the final fluorescence emission intensity of the solution as we expected, and this increase comes from the effective operation of the DNA circuit. These results also fully demonstrate the feasibility and design rationality of the fluorescence detection method of the present application.

[0073] Specificity Verification:

[0074] The experimental process is the same as above. The difference is that in step (3), the 50 μL test solution contains 100 ng / mL OPN and 1 μg / mL OC, ALP, BSA and blank control. OC and ALP are two bone health-related proteins that also exist in the blood, and BSA is used to simulate the albumin that exists in large quantities in the blood. PBA-T is used for experiments and tests, and the test results are as follows: Figure 6 shown.

[0075] Figure 6 The fluorescence emission intensity of the final solution obtained when the fluorescence detection method of the present application is used to detect the target glycoprotein OPN and a variety of control proteins is shown. When the control protein concentration is as high as 1 μg / mL in the system, the fluorescence emission intensity of the final solution near 520nm is only equivalent to that of the blank control group, which is much lower than the fluorescence emission intensity obtained when 100 ng / mL OPN is present in the system. This result shows that the detection method of the present application has excellent specificity when used for the target glycoprotein OPN.

[0076] Example 2

[0077] The glycoprotein detection method based on boric acid recognition in the present application has the same steps as in Example 1, except that in step (3), 100 μL of Apt@MBs prepared in step (1) and 50 μL of sample solution containing different concentrations of target glycoprotein OPN are placed in a microtube and reacted at 20°C for 0.5 hours. The detection results are as follows: Figure 7 and Figure 8 shown.

[0078] Figure 7 The fluorescence emission spectra of the final solution obtained when the fluorescence detection method of the present application is used to detect different concentrations of the target glycoprotein OPN are shown. As shown in the figure, the continuous increase in the OPN concentration causes the fluorescence emission peak of the detection solution near 520nm to gradually increase, which means that as the OPN concentration increases, more and more PBA-T can be anchored to the surface of the magnetic beads by the interaction between phenylboronic acid and the sugar chain in the target glycoprotein molecule, so that it can more efficiently catalyze the operation of the DNA circuit and produce a stronger fluorescence response.

[0079] Figure 8 The linear relationship between the fluorescence emission intensity of the final solution at around 520 nm and the logarithmic value of the OPN concentration is shown when the concentration of the target glycoprotein OPN is in the range of 1 pg / mL to 100 ng / mL. The linear regression equation is F 520 =919.2LgC OPN +1344.5(R 2 =0.998). According to the ratio between the minimum quantitative concentration and its fluorescence emission intensity and 3.3 times the standard deviation of the blank group (reference Anal.Chem.2021,93,12156-12161), it is deduced that the minimum detection limit of this method for OPN detection is 0.289pg / mL. For each concentration, at least three independent repeated tests were performed. According to the results, the relative standard deviation of the developed fluorescence method for detecting OPN at different concentrations was calculated to be no higher than 3.67%, reflecting ideal repeatability. At the same time, by comparison with existing methods or commercial kits, the method of the present application has a lower detection limit and a wider linear range when used for OPN detection.

[0080] The above-mentioned existing methods include:

[0081] (1)Analytica Chimica Acta Volume 1198,15March 2022,339557,

[0082] Colorimetric

[0083] Linear range:50~1000ng / mL

[0084] Detection limit:50ng / mL,

[0085] (2)Analytica Chimica Acta Volume 987,22September 2017,Pages25-37,

[0086] Electrochemical

[0087] Linear range:12~100nM

[0088] Detection limit:1.4nM(~91ng / mL),

[0089] (3)Talanta Volume 210,1April 2020,120624,

[0090] Colorimetric

[0091] Linear range:10ng / mL~500ng / mL

[0092] Detection limit:10ng / mL,

[0093] (4)New J.Chem.,2022,46,20629-20642,

[0094] SERS-LFA

[0095] Linear range:1pg / mL~1μg / mL

[0096] Detection limit:0.86pg / mL,

[0097] (5)Biotechnol Appl Biochem.2022;69:1733–1740,

[0098] Electrochemical

[0099] Linear range: 0.3~5ng / mL

[0100] Detection limit: 0.6ng / mL.

[0101] The above-mentioned commercial kits include: Human Osteopontin ELISA Kit (ab269374), Osteopontin / SSP1 Human ELISA Kit, Human Osteopontin ELISA Kit.

[0102] Example 3

[0103] The glycoprotein detection method based on boric acid recognition in simulated serum samples is to prepare simulated serum samples (the final concentrations of OPN are 20pg / mL, 1ng / mL and 10ng / mL, respectively) by dissolving different concentrations of target glycoprotein OPN in 50% fetal bovine serum. The steps are the same as those in Example 1, except that in step (3), 100μL of Apt@MBs prepared in step (1) and 50μL of simulated serum samples containing the above-mentioned different concentrations of target glycoprotein OPN and buffer samples of the same concentration are placed in a microtube. The test results are as follows: Fig. 9 shown.

[0104] pass Fig. 9 It can be seen that the fluorescence intensity obtained when the fluorescence detection method of the present application is used to detect the same concentration of target glycoprotein OPN in buffer and simulated serum samples is comparable.

[0105] Table 2 further shows that the relative standard deviation of the detection of OPN in simulated serum samples using the method of the present application is 2.93% to 5.38%, and the recovery rate is 102.46% to 106.44%, indicating that the method of the present application still has good feasibility and accuracy in simulated serum samples with complex composition, and can meet the needs of actual clinical sample analysis.

[0106] Table 2

[0107]

[0108] Example 4

[0109] The present invention relates to a glycoprotein detection method based on boric acid recognition, and the steps are the same as those of Example 1, except that in step (1), the obtained magnetic beads are resuspended in 300 μL of Tris-HCl buffer containing 10 μM amino-modified OC nucleic acid aptamer, and the reaction is carried out at 25° C. for 1 hour (during the reaction, the solution is shaken for 15 seconds every 30 minutes). The sequence of the OC nucleic acid aptamer is 5′-GGCGATGAGAACGGGAGCCTGATGATACACACGAGCGATCGCTCATAA AAGCCGTGCCCG-3′ (SEQ ID NO: 11), and the sequence of the amino-modified OC nucleic acid aptamer is 5′-NH2-C12-AAAAAA-GGCGATGAGAACGGGAGCCTGATGATACACACGAGCGATCGCTCATAAAAGCCGTGCCCG-3′. And in step (3), 100 μL of the obtained Apt@MBs and 50 μL of the test solution [including sample solutions containing different concentrations of target glycoprotein OC, control solutions containing 1 μg / mL control proteins (OPN, ALP, BSA), and blank control solutions without any protein] were placed in a microtube and reacted at 25°C for 1 hour. Fig.10 A. The fluorescence emission spectra obtained when detecting different concentrations of OC are shown in Fig.10 B. The linear relationship between the fluorescence emission intensity at 520 nm and the logarithmic value of OC concentration is shown in Fig.10 C. Specificity verification is shown in Fig.10 As shown in D.

[0110] Fig.10 The figure shows the performance of the fluorescence method of the present application when used to detect the target glycoprotein OC. Fig.10 As shown in B, the continuous increase in OC concentration caused the gradual enhancement of the fluorescence emission peak of the detection solution near 520 nm. Fig.10 C shows the linear relationship between the fluorescence emission intensity of the final solution at around 520 nm and the logarithmic value of OC concentration when the target glycoprotein OC concentration ranges from 0.5 pg / mL to 50 ng / mL. The linear regression equation is F 520 =920.8LgC OC +1598.3(R 2=0.996). According to the ratio between the lowest quantitative concentration and its fluorescence emission intensity and 3.3 times the standard deviation of the blank group, the lowest detection limit of this method for OC detection is calculated to be 0.127pg / mL. At least three independent repeated tests were performed for each concentration. According to the results, the relative standard deviation of the developed fluorescence method for OC detection at different concentrations was calculated to be no higher than 4.14%, reflecting ideal repeatability. At the same time, by comparison with existing methods or commercial kits, the detection method of the present application has a lower detection limit and a wider linear range when used for OC detection. Fig.10 D shows the fluorescence emission intensity of the final solution obtained when the fluorescence method of the present application is used to detect the target glycoprotein OC and a variety of control proteins. When the control protein concentration is as high as 1 μg / mL in the system, the fluorescence emission intensity of the final solution near 520nm is only equivalent to that of the blank control group, which is much lower than the fluorescence emission intensity obtained when 100 ng / mL OC is present in the system. This result shows that the fluorescence method of the present application has excellent specificity when used for the target glycoprotein OC.

[0111] The above existing methods include:

[0112] (1)Talanta Volume 224,1March 2021,121818,

[0113] Fluorescence

[0114] Linear range: 1~100pg / mL

[0115] Detection limit: 0.4pg / mL,

[0116] (2)Talanta Volume 238,Part 1,1February 2022,123001,

[0117] Colorimetric

[0118] Linear range: 0.1~50ng / mL

[0119] Detection limit: 0.042ng / mL,

[0120] (3)Biotechnol Appl Biochem.2022;69:2061–2068,

[0121] Electrochemical

[0122] Linear range: 0.01~3000ng / mL

[0123] Detection limit: 100pg / mL,

[0124] (4)Int.J.Electrochem.Sci.,17(2022)Article Number:22109,

[0125] Electrochemical

[0126] Linear range: 2.0~1250ng / mL

[0127] Detection limit: 2.0ng / mL,

[0128] (5)Anal.Methods,2018,10,2470-2480,

[0129] Chemiluminescent

[0130] Linear range: 0~52ng / mL

[0131] Detection limit: 0.36ng / mL.

[0132] The commercial kits mentioned above include: Human Osteocalcin ELISA Kit (ab270202), Osteocalcin Human ELISA Kit, Human Osteocalcin ELISA Kit.

[0133] Obviously, the above embodiments are only examples for clear explanation, and are not intended to limit the implementation methods. For those skilled in the art, other different forms of changes or modifications can be made based on the above description, and it is not necessary and impossible to list all the implementation methods here.

Claims

1. A probe for glycoprotein detection based on boric acid recognition, characterized in that: It includes a priming probe T and six hairpin loop probes H1, H2, H3, H4, H5, and H6, wherein the priming probe T includes a core fragment and a polyT fragment, wherein the core fragment includes a sequence as shown in SEQ ID NO: 7, The probe H1 is partially complementary to the core fragment of the trigger probe T, and the probe H1 and the trigger probe T hybridize to form a T-H1 double strand. The probe H2 is partially complementary to the probe H1, and the probe H2 hybridizes to form a H1-H2 double strand, exposing a single strand fragment I. The probe H3 is partially complementary to the single-stranded fragment I, the probe H4 is partially complementary to the single-stranded fragment I, the probe H5 is partially complementary to the probe H4, the probe H5 is labeled with a fluorescent group and a quenching group, the probe H6 is partially complementary to the probe H5, and H3, H4, H5 and H6 are hybridized in sequence in the presence of the single-stranded fragment I to form a long chain I-(H3-H4-H5-H6) n , the long chain I-(H3-H4-H5-H6) n The sequence of the priming probe T is exposed.

2. The glycoprotein detection probe based on boronic acid recognition according to claim 1, characterized in that: The fluorescent group includes FAM, JOE, Cy3 or TAMRA, and the quenching group includes BHQ1, BHQ2 or Dabcyl.

3. The glycoprotein detection probe based on boronic acid recognition according to claim 1, characterized in that: The fluorescent group and the quenching group are modified at both ends of the probe respectively.

4. The glycoprotein detection probe based on boronic acid recognition according to claim 1, characterized in that: The polyT fragment is 6 to 8 consecutive thymines.

5. The glycoprotein detection probe based on boronic acid recognition according to claim 1 or 2, characterized in that: The probe H1 includes the sequence shown in SEQ ID NO: 1, the probe H2 includes the sequence shown in SEQ ID NO: 2, the probe H3 includes the sequence shown in SEQ ID NO: 3, the probe H4 includes the sequence shown in SEQ ID NO: 4, the probe H5 is based on the sequence of SEQ ID NO: 5, with a FAM fluorescent group labeled between positions 12 and 13, and a BHQ1 quenching group labeled between positions 42 and 43, and the probe H6 includes the sequence shown in SEQ ID NO:

6.

6. Use of the probe according to any one of claims 1 to 5 in the preparation of a glycoprotein detection product based on boric acid recognition.

7. A glycoprotein detection method based on boric acid recognition, characterized in that: The detection using the probe according to any one of claims 1 to 5 comprises the following steps: (1) Taking the activated magnetic bead solution for magnetic separation, after washing, coupling the carboxyl group on the surface of the magnetic beads with the amino group at the end of the target protein nucleic acid aptamer to obtain aptamer-functionalized magnetic beads, (2) After the activation of the trigger probe T, the carboxyl group at the terminal of the trigger probe T is coupled with the amino group of the compound A having both an amino group and a phenylboronic acid group to obtain the modified trigger probe T. (3) reacting the aptamer-functionalized magnetic beads with the sample to be tested, washing, resuspending the obtained magnetic beads, adding the modified initiating probe T to the resuspended solution for reaction, washing, resuspending the obtained magnetic beads, and sequentially adding the probes H1, H2, H3, H4, H5, and H6 to the resuspended solution for reaction, (4) Measure the fluorescence signal of the supernatant obtained in step (3).

8. The method for detecting glycoproteins based on boric acid recognition according to claim 7, characterized in that: The activation reagent used in step (1) is 1-ethyl-(3-dimethylaminopropyl)carbodiimide or NHS, and the activation reagent used in step (2) is NHS and N-(3-dimethylaminopropyl)-N'-ethylcarbodiimide hydrochloride.

9. The method for detecting glycoproteins based on boric acid recognition according to claim 7, characterized in that The compound A in step (2) is 3-aminophenylboronic acid.

10. Use of a glycoprotein detection method based on boric acid recognition according to any one of claims 7 to 9 in the detection of osteopontin or osteocalcin.

Citation Information

Cited By

  • Probe group and method for analyzing specific glycoprotein sialic acid on exosome surface by combining probe group with 3D printing micro-fluidic chip

    CN120174094A

  • Mucin hydrogel loaded with cerium-dihydromyricetin nano-enzyme as well as preparation method and application of mucoprotein hydrogel

    CN121588029A

  • A mucin hydrogel loaded with cerium-dihydromyricetin nanoszyme, a preparation method and application thereof

    CN121588029B